Combined mechanical circulatory support (Impella + ECMO) in cardiogenic shock caused by fulminant myocarditis

Combined mechanical circulatory support (Impella + ECMO) in cardiogenic shock caused by fulminant myocarditis

Saved in:

Bibliographic Details
Main Authors:	Michaela Zemkova, Daniel Rob, Milan Dusík, Jan Pudil, Tomas Palecek, Ivana Vitkova, Jan Belohlavek
Format:	Article
Language:	English
Published:	Wiley 2025-02-01
Series:	ESC Heart Failure
Subjects:	Cardiogenic shock ECMO Fulminant myocarditis Impella Mechanical circulatory support devices
Online Access:	https://doi.org/10.1002/ehf2.15001
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Trends and outcomes of different mechanical circulatory support modalities for refractory cardiogenic shock in Takotsubo cardiomyopathy
by: Shafaqat Ali, et al.
Published: (2025-06-01)

A race against time: A case report of fulminant myocarditis leading to cardiogenic shock
by: Martin Joseph, et al.
Published: (2024-03-01)

Combined Risk Stratification With Patient Characteristics and Biomarkers in Patients Treated With the Impella for Cardiogenic Shock
by: Yuichi Saito, et al.
Published: (2025-05-01)

Cardiogenic shock — the current state of the problem
by: S. A. Boytsov, et al.
Published: (2019-11-01)

Impella malrotation affects left ventricle unloading in cardiogenic shock patients
by: Luca Baldetti, et al.
Published: (2025-02-01)

ECMO combined with IABP for the treatment of fulminant myocarditis caused by the targeted drug entrectinib for lung adenocarcinoma: a case report
by: Qi Yujuan, et al.
Published: (2025-08-01)

Fulminant dengue myocarditis requiring VA ECMO support
by: Nanda Kishor Vuppali, et al.
Published: (2018-12-01)

Implications of mechanical circulatory support devices in a pregnant woman with cardiogenic shock
by: Johanna A. van der Zande, et al.
Published: (2025-01-01)

Percutaneous mechanical circulatory support for acute right heart failure: A practical approach
by: Mario Gramegna, et al.
Published: (2025-08-01)

Clinical and pathological characteristics of immune checkpoint inhibitor-related fulminant myocarditis
by: Ryo Izumi, et al.
Published: (2024-11-01)

Cardiac shock care center — the next stage in the treatment of cardiogenic shock
by: S. A. Boytsov, et al.
Published: (2019-11-01)

Acute Circulatory Collapse and Advanced Therapies in Patients with COVID-19 Infection
by: Rishi Thaker, et al.
Published: (2021-12-01)

Extracorporeal cardiopulmonary resuscitation successfully used in a two-hour cardiac arrest caused by fulminant myocarditis: a case report
by: Qinxue Hu, et al.
Published: (2024-10-01)

Long-term left ventricular ejection function in fulminant and non-fulminant myocarditis: A multicenter study in China
by: Guangling Li, et al.
Published: (2025-08-01)

Lactate Dehydrogenase Indicates Development From Fulminant Myocarditis to Chronic Persistent Myocarditis: A Multicenter Retrospective Cohort Study in China
by: Zhao Q, et al.
Published: (2025-03-01)

Outbreak of Acute Fulminant Myocarditis in Children in Campania Region, Italy: A Case Series
by: Antonietta Giannattasio, et al.
Published: (2024-11-01)

Evaluating gender-based disparities in the outcomes of impella use in acute myocardial infarction patients with cardiogenic shock; insights from real-world global data
by: Abdul Wali Khan, et al.
Published: (2025-07-01)

Head-to-head comparison of V-A ECMO, Impella and ECPELLA in normal ovine hearts
by: Konstantin Yastrebov, et al.
Published: (2025-07-01)

Protocol‐Driven Best Practices and Cardiogenic Shock Survival in Asian Patients
by: Calvin Leung, et al.
Published: (2025-03-01)

Successful Treatment of Large Left Ventricular Thrombosis During Extracorporeal Membrane Oxygenation (ECMO): A Case Report and Review of the Literature
by: Xue‐ting Yang, et al.
Published: (2025-01-01)

Analysis of risk factors affecting prognosis of fulminant myocarditis in children: a ten-year single-center study
by: Jia Yuan, et al.
Published: (2025-03-01)

Impella 5.5 as a bridge-to-surgery in acute ischemic mitral regurgitation post-percutaneous coronary intervention: a case report
by: Ioana Dumitru, et al.
Published: (2024-11-01)

Single arterial access for Ecpella and jugular venous cannulation provides full mobility on a status 1 heart transplant recipient
by: Macit Bitargil, et al.
Published: (2022-06-01)

Recognizing Post-Cardiac Injury Syndrome After Impella 5.5 Insertion in Cardiogenic Shock: A Case-Based Discussion
by: Aarti Desai, et al.
Published: (2025-07-01)

Fulminant myocarditis associated with human rhinovirus A66 infection: a case report
by: Shuaibing Han, et al.
Published: (2024-10-01)

Impella 5.5 use in women: A multicenter study
by: Michaela Asher, MPhil, et al.
Published: (2025-08-01)

ECMO and impella increase stroke risk in acute myocardial infarction
by: Jing Wu, et al.
Published: (2025-07-01)

Extracorporeal membrane oxygenation for the support of pediatric patients with acute fulminant myocarditis
by: Güntülü Şık, et al.
Published: (2019-12-01)

Dramatic Improvement of Acute Fulminant Lymphocytic Myocarditis with Short-course Intravenous Pulse Corticosteroids: A Case Study
by: Abdelfatah Elasfar, et al.
Published: (2024-10-01)

Shock and Awe: The Tactical Trade-Offs of Impella<sup>®</sup> Versus Intra-Aortic Balloon Pump in Takotsubo Cardiomyopathy
by: Ajay Saraf, et al.
Published: (2025-04-01)

Short- and long-term outcomes of Impella-protected, high-risk, elective PCI in patients with multivessel coronary disease and low ejection fraction — Polish Impella Registry
by: Wojciech J. Skorupski, et al.
Published: (2025-06-01)

Does Levosimendan hasten veno-arterial ECMO weaning? A propensity score matching analysis
by: Nicolas Paulo, et al.
Published: (2025-04-01)

A rare case report: fulminant myocarditis in neonatal lupus erythematosus
by: Shujun Tan, et al.
Published: (2025-07-01)

Fatal idiopathic giant cell myocarditis in a young male: a diagnostic and therapeutic dilemma in a resource-limited setting
by: N. M. M. Risly, et al.
Published: (2025-08-01)

Successful Treatment of Left Ventricle Inferior Wall Perforation and Rupture Associated with an Impella 5.5: A Case Report
by: James Hall, et al.
Published: (2025-06-01)

HEART TRANSPLANTATION FOR FULMINANT MYOCARDITIS AFTER PROLONGED ECMO
by: K. O. Barbukhatti, et al.
Published: (2013-05-01)

Cardiac power output ratio: Novel survival predictor after percutaneous ventricular assist device in cardiogenic shock
by: Calvin Leung, et al.
Published: (2024-12-01)

Multicentre comparison of various microaxial pump devices as a bridge to durable assist device implantation
by: Marta L. Medina, et al.
Published: (2025-08-01)

A rare case report: acute necrotizing encephalopathy and acute fulminant myocarditis
by: Juan Ma, et al.
Published: (2025-05-01)

Management of Myocardial Infarction: Emerging Paradigms for the Future
by: Vandan D. Upadhyaya, et al.
Published: (2024-08-01)